Post Term: BIO-TIC

BIO-TIC Pragmatic recommendations for action

BIO-TIC Pragmatic recommendations for action

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

Principal barrier to European industrial biotechnology development was cost-competitiveness, both compared to fossil alternatives and compared to other regions of the world. This was affected by many factors including the cost of feedstock, technology readiness levels, and the market support for bio-based products. The cost competitiveness issue was compounded by difficulties in accessing finance for large scale projects, an often low end user awareness of IB derived products and by a lack of skills and operational alliances to drive the sector forward.

This press release discusses ten pragmatic recommendations for action to tackle identified barriers and hurdles, and to ensure that most of the market potential is realised in Europe. These cover feedstock issues (improve the opportunities for feedstock producers within the bioeconomy, investigate the scope for using novel biomass), processing issues (promote the use of co-products from processing, improve the bioconversion and downstream processing steps, identify, leverage and build upon EU capabilities for pilot and demonstration facilities), investment challenges (introduce a long-term, stable and transparent policy and incentive framework to promote the bioeconomy, and improve access to finance for large-scale projects) and support for innovation more generally (develop the skills needed now and in the future for the IB industry, assess and improve public perception and awareness of IB and bio-based products, develop stronger relationships between conventional and non-conventional players).

BIO-TIC Summary of hurdles and solutions in industrial biotechnology

BIO-TIC Summary of hurdles and solutions in industrial biotechnology

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

This document provides a concise overview of main hurdles and solutions collected during the multi-stakeholders iterative process. Presented solutions are discussed in more depth within either the BIO-TIC R&D roadmap or the BIO-TIC non-technological roadmap.

BIO-TIC Non-technological roadmap

BIO-TIC Non-technological roadmap

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

The non-technological roadmap identifies regulatory and non-technological hurdles that may prevent IB innovation from taking advantage of market opportunities., and proposes solutions for key market entry barriers.

BIO-TIC R&D roadmap

BIO-TIC R&D roadmap

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

The R&D roadmap revolves around the setting of R&D priorities and identifying needs for research, pilot and demonstration plant activities.  The analysis focuses on the identification of R&D bottlenecks and required breakthroughs for large-scale deployment of industrial biotechnology in Europe by 2030 across a broad range of technological domains.  

BIO-TIC Market roadmap

BIO-TIC Market roadmap

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

The market roadmap aims to obtain an a comprehensive overview of the market potential for industrial biotechnology, the current and potential future value chain composition and stakeholders, including segmented market opportunity assessment and projections. It provides an overview of the current state of the industrial biotechnology market in the EU and evaluates its growth potential through to 2030. It describes the value chain composition of each of five BIO-TIC product categories (i.e. advanced biofuels (advanced ethanol and bio-based jet fuels), biosurfactants, bioplastics, bio-based chemical building blocks, and the use of IB to convert CO2 into various downstream products). In addition, it outlines their expected market shares in 2030.

BIO-TIC – The Industrial Biotech Research and Innovation Platforms Centre – towards Technological Innovation and solid foundations for a growing industrial biotech sector in Europe

BIO-TIC – The Industrial Biotech Research and Innovation Platforms Centre – towards Technological Innovation and solid foundations for a growing industrial biotech sector in Europe

The project goal is to draw-up a blueprint document of recommendations for overcoming the innovation hurdles within a selection of targeted business market segments that can make a major contribution to an accelerated take-up of industrial biotechnology (IB) into the market place.
This will involve:

  • Analysis of existing knowledge bank relating to market, research and institutional barriers hindering uptake of IB technology innovations into the market place
  • Engagement with a broad range of stakeholders across the full multidisciplinary IB spectrum to update, develop and validate these innovation barriers to market entry
  • Formulation of a roadmap of action plans and policy recommendations for accelerated uptake of IB into a number of targeted product segment areas

Bio-TIC will compile an in-depth preparation of three “interim roadmaps” comprising market projections, R&D priorities and non-technological barriers to IB market entry. These will act to guide and facilitate a series of convened stakeholder workshops at both national and European level for a full discussion on innovation barriers, in order to validate and further elaborate more comprehensive roadmaps, while taking on board the totality of views from the diverse IB stakeholder base. Finally, the partners will collate and further refine the developed roadmaps into a joint European IB Roadmap and Policy recommendations document, with maximum stakeholder buy-in for wide dissemination and maximum impact.

The project will be co-ordinated by EuropaBio- the European Association for Biotechnology Industries, who will also be joined by CEFIC, the European Chemical Industry Council, representing the European chemical industry. These will be joined in the consortium by a further 9 members incorporating innovation agencies, cluster organisations and private management consultancies; all of whom have many complementary skills and expertise and who have worked together in the past on similar initiatives.

  • Grant Agreement ID
    312121
  • Call Topic
    FP7-KBBE
  • Project Website
  • Duration
    From: 2012-08-01
    To: 2015-07-31
  • Overall Budget
    2 809 777,60 €
  • Coordinator
    EUROPABIO – The European Association of Bioindustries

PROJECT CONTENTS

BIO-TIC Market roadmap
The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations
Read more
BIO-TIC Non-technological roadmap
The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations
Read more
BIO-TIC Pragmatic recommendations for action
The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations
Read more
BIO-TIC R&D roadmap
The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations
Read more
BIO-TIC Summary of hurdles and solutions in industrial biotechnology
The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations
Read more